Altimmune, Inc.

ALT

$3.93

Name : Altimmune, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $346,851,008.00

EPSttm : -1.18

Altimmune, Inc.

$3.93

0.00%

$0.0000

Float Short %

28.7

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

-0.05

EPS Last/This Y

0.21

EPS This/Next Y

-0.25

Price

3.92

Target Price

17.75

Analyst Recom

1.67

Performance Q

-10.68

Relative Volume

2.64

Beta

0.01

Ticker: ALT

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	ALT	3.7	0.18	0.39	198096
2025-09-09	ALT	3.78	0.19	0.15	199497
2025-09-10	ALT	3.67	0.19	0.31	201371
2025-09-11	ALT	3.68	0.19	0.31	203752
2025-09-12	ALT	3.63	0.19	0.14	204919
2025-09-15	ALT	3.59	0.19	0.64	203794
2025-09-16	ALT	3.64	0.19	0.98	206493
2025-09-17	ALT	3.57	0.192621466393	0.58887677208288	207441
2025-09-18	ALT	3.86	0.19	0.08	208581
2025-09-22	ALT	3.95	0.24	0.11	169039
2025-09-23	ALT	3.8	0.23	0.09	177076
2025-09-24	ALT	3.93	0.23	0.27	179504
2025-09-25	ALT	3.92	0.22	0.38	194043
2025-09-26	ALT	3.98	0.23	0.15	199893
2025-09-29	ALT	3.79	0.23	0.90	194248
2025-09-30	ALT	3.77	0.24	0.45	196847
2025-10-01	ALT	3.86	0.24	0.11	197514
2025-10-02	ALT	3.92	0.24	0.15	203965
2025-10-03	ALT	3.9	0.24	0.12	205054
2025-10-06	ALT	4.01	0.24	0.09	201615
2025-10-07	ALT	3.92	0.24	0.08	202255
2025-10-08	ALT	3.92	0.24	0.06	203362
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	ALT	3.71	16.2	-75.7	-1.13
2025-09-09	ALT	3.78	16.2	-88.8	-1.13
2025-09-10	ALT	3.67	16.2	-72.1	-1.13
2025-09-11	ALT	3.69	16.2	-83.6	-1.13
2025-09-12	ALT	3.63	16.2	-76.0	-1.13
2025-09-15	ALT	3.59	16.2	-77.5	-1.13
2025-09-16	ALT	3.63	16.2	-85.8	-1.13
2025-09-17	ALT	3.57	16.2	-76.4	-1.13
2025-09-18	ALT	3.86	16.2	-112.1	-1.13
2025-09-19	ALT	3.77	16.2	-74.3	-1.13
2025-09-22	ALT	3.96	16.2	-99.2	-1.13
2025-09-23	ALT	3.80	16.2	-69.0	-1.13
2025-09-24	ALT	3.93	16.2	-94.8	-1.13
2025-09-25	ALT	3.92	16.2	-86.4	-1.13
2025-09-26	ALT	4.00	16.2	-88.5	-1.13
2025-09-29	ALT	3.78	16.2	-64.8	-1.13
2025-09-30	ALT	3.77	16.2	-80.4	-1.13
2025-10-01	ALT	3.87	16.2	-90.6	-1.13
2025-10-02	ALT	3.93	16.2	-87.7	-1.13
2025-10-03	ALT	3.91	16.2	-80.2	-1.13
2025-10-06	ALT	4.02	16.2	-90.1	-1.13
2025-10-07	ALT	3.92	16.2	-74.6	-1.13
2025-10-08	ALT	3.92	16.2	-81.5	-1.13
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	ALT	1.29	-1.38	29.13
2025-09-09	ALT	1.29	-1.38	29.13
2025-09-10	ALT	1.29	-1.38	29.13
2025-09-11	ALT	1.29	-1.38	30.63
2025-09-12	ALT	1.29	-1.38	30.63
2025-09-15	ALT	0.12	-1.30	30.63
2025-09-16	ALT	0.12	-1.30	30.63
2025-09-17	ALT	0.12	-1.30	30.63
2025-09-18	ALT	0.12	-1.30	30.63
2025-09-19	ALT	0.00	-1.30	30.63
2025-09-22	ALT	0.00	-1.30	30.63
2025-09-23	ALT	0.00	-1.30	30.63
2025-09-24	ALT	0.00	-1.30	30.63
2025-09-25	ALT	0.00	-1.30	28.70
2025-09-26	ALT	0.00	-1.30	28.70
2025-09-29	ALT	0.00	-1.28	28.70
2025-09-30	ALT	0.00	-1.28	28.70
2025-10-01	ALT	0.00	-1.28	28.70
2025-10-02	ALT	0.00	-1.28	28.70
2025-10-03	ALT	0.00	-1.28	28.70
2025-10-06	ALT	0.00	-0.56	28.70
2025-10-07	ALT	0.00	-0.56	28.70
2025-10-08	ALT	0.00	-0.56	28.70
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

-0.27

Avg. EPS Est. Current Quarter

-0.27

Avg. EPS Est. Next Quarter

-0.32

Insider Transactions

Institutional Transactions

-0.56

Beta

0.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

84.1

Max Drawdown 5-Year %

-91.2

Target Price

17.75

P/E

Forward P/E

PEG

P/S

17342.5

P/B

2.07

P/Free Cash Flow

EPS

-1.18

Average EPS Est. Cur. Y

-1.13

EPS Next Y. (Est.)

-1.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-438730

Relative Volume

2.64

Return on Equity vs Sector %

-79.6

Return on Equity vs Industry %

-65.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-81.5

Altimmune, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 59

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

stock quote shares ALT – Altimmune, Inc. Stock Price stock today

news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALT – Altimmune, Inc. yahoo finance google finance

stock history ALT – Altimmune, Inc. invest stock market

stock prices ALT premarket after hours

ticker ALT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ALT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y